2‐Methoxyestradiol, a Promising Anticancer AgentNehal J. Lakhani, William D. Figg, Mohamadi Sarkar et al.|Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy|2003Cited by 276
Phase I clinical trial of oral 2-methoxyestradiol, an antiangiogenic and apoptotic agent, in patients with solid tumorsWilliam L. Dahut, William D. Figg, Seth M. Steinberg et al.|Cancer Biology & Therapy|2006Cited by 155
Design, Synthesis, and Biological Evaluation of Ester and Ether Derivatives of Antisickling Agent 5-HMF for the Treatment of Sickle Cell DiseaseGuoyan Xu, Osheiza Abdulmalik, Qiukan Chen et al.|Molecular Pharmaceutics|2017Cited by 55
Crystallographic analysis of human hemoglobin elucidates the structural basis of the potent and dual antisickling activity of pyridyl derivatives of vanillinOsheiza Abdulmalik, Martin K. Safo, Mohini S. Ghatge et al.|Acta Crystallographica Section D Biological Crystallography|2011Cited by 53
Characterization of in vitro and in vivo metabolic pathways of the investigational anticancer agent, 2‐methoxyestradiolNehal J. Lakhani, William D. Figg, Alex Sparreboom et al.|Journal of Pharmaceutical Sciences|2007Cited by 38